Study finds vaccination is the most cost-effective way to reduce rabies deaths in India

January 11, 2017

Every year in India, 20,000 people are estimated to die from rabies. Most of the victims are children. Nearly all of the deaths occur after victims are bitten by rabid dogs. For years, experts have debated the best strategy to reduce this burden.

Now, a new study has identified a cost-effective way to reduce death due to rabies. The research, led by a scientist at the University of Maryland School of Maryland (UM SOM) Center for Vaccine Development (CVD), was published recently in the journal Proceedings of the National Academy of Sciences.

The study focused on the Indian state of Tamil Nadu, in the south of the country. Researchers found that over the course of five years, vaccinating 200,000 stray dogs a year would reduce rabies incidence by 90 percent. They estimated this strategy would cost about $1.27 million annually.

"We wanted to evaluate the cost-effectiveness of different rabies control strategies," said the lead researcher on the study, Meagan C. Fitzpatrick, a post-doctoral fellow at CVD. "Our goal was to maximize the impact of vaccination and/or sterilization on human health outcomes in the real world, where policymakers operate within cost constraints."

The research team also included scientists from the Yale School of Public Health, the Public Health Foundation of India, the Harvard School of Public Health, and the London School of Hygiene and Tropical Medicine.

India accounts for more than a third of the world's rabies deaths. Stray dogs are common and comprise approximately 42 percent of the total canine population in Tamil Nadu.

Dr. Fitzpatrick and her colleagues examined a range of strategies aimed at stray dogs, including vaccination as well as combined vaccination and sterilization. They also looked at different numbers of dogs captured and treated per day, to identify the most efficient scale for the program. The ten-year cumulative cost of these programs ranged from $12 million to $72 million. Indian decision-makers face competing health priorities, and as a result, reducing rabies must be cost-effective.

The researchers used a measurement known as Disability-Adjusted Life Year, or DALY, to compare the efficiency of each approach. A DALY is defined as a lost year of healthy life. Dr. Fitzpatrick measured how many DALYs each strategy would save, allowing her to compare costs. Based on this approach, a strategy of vaccination without sterilization was the most efficient way to reduce death from rabies.

Rabies is a viral disease of mammals that is usually transmitted via the bite of a rabid animal. In the U.S., most rabies cases involve wild animals such as raccoons, skunks, bats, and foxes. The rabies virus attacks the central nervous system, eventually causing disease in the brain and death. Death usually occurs within days of the appearance of symptoms (symptoms may not appear for a month or longer following a bite from a rabid animal). If people are treated within two or three days of being bitten, the vaccine is highly effective, and victims usually survive. As a result, deaths are extremely rare in the U.S. Being bitten by a rabid animal is also very rare in the U.S. because nearly all domesticated animals are vaccinated. In India, however, victims often do not get treatment, either because they don't know they've been infected, or don't have the means to get to a clinic or to pay for treatment.

Explore further: Every nine minutes, someone in the world dies of rabies

More information: Meagan C. Fitzpatrick et al. One Health approach to cost-effective rabies control in India, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1604975113

Related Stories

Every nine minutes, someone in the world dies of rabies

October 1, 2015
A human death from rabies is a tragic but rare thing in the United States and most developed nations. It's just as tragic but sadly common in parts of the world where some 3 billion people are at risk of being bitten by a ...

Rabies vaccine effective even after warm storage

October 24, 2016
A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

Canine vaccinations effective deterrent to rabies in Africa

January 22, 2014
(Medical Xpress)—Yale School of Public Health researchers have found that annual canine vaccination campaigns not only stop the spread of rabies, a potentially deadly disease, but are cost-effective and may actually save ...

160 people die of rabies every day, says major new study

April 16, 2015
A global study on canine rabies, published today (16 April 2015), has found that 160 people die every single day from the disease. The report is the first study to consider the impact in terms of deaths and the economic costs ...

Protect yourself and your pet from rising threat of rabies

May 19, 2015
A bat flying erratically during daylight hours, a raccoon slowly wandering down the middle of a road, a fox that does not run away when you approach, a dead skunk in your horse's corral.

Recommended for you

Researchers developing new tool to distinguish between viral, bacterial infections

July 28, 2017
Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians ...

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.